SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...

The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.

Holding “announced a business restructuring to streamline operations and reduce costs. In addition, 23andMe is discontinuing ...

DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...

Bay Area genetic testing company 23andMe announced Monday that it plans to lay off 40% of its workforce as part of a broader restructuring effort aimed at cutting costs and refocusing the company on ...

Monday’s restructuring comes as 23andMe weathers months of difficulties. Since its initial public offering in 2021, the ...

"This makes public trust in these services essential," it added. In another blow to the company, seven of 23andMe’s ...

Prior to that, 23andMe’s independent directors—Roelof Botha, Patrick Chung, Sandra Hernández, Neal Mohan, Valerie Montgomery ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

Genetic testing company 23andMe has appointed three new independent directors to its board, including former WeWork CFO Andre ...